Diarrheal diseases, particularly those caused by rotavirus, are a significant global health burden, especially in young children. Rotavirus is one of the leading causes of severe diarrhea in infants and young children worldwide, leading to substantial morbidity and mortality. In the quest for effective treatments, Nitazoxanide 500 mg has emerged as a potential therapeutic agent. […]
